Surrey, Canada

Mike Adam

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Nordion (Canada) Inc.. Active years: 2014.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mike Adam

Introduction

Mike Adam is an accomplished inventor based in Surrey, Canada. He is known for his significant contributions to the field of chelating agents, particularly through his innovative patent. With a focus on developing solutions that bridge chemistry and medicine, Adam has made strides in creating effective pharmaceutical compositions.

Latest Patents

Mike Adam holds a patent for bifunctional chelating agents. This patent describes a bifunctional chelating agent of the formula (I), wherein the variables R, R, Q, Q, and M are defined in the description of the present application. The patent also details a complex of the chelating agent with an ion of a stable or radioactive metal, a conjugate of the complex covalently attached to a biological carrier, and a pharmaceutical composition containing the conjugate. This innovation has potential applications in various medical fields.

Career Highlights

Throughout his career, Mike Adam has worked with notable companies, including Nordion Canada Inc. and Bwxt Medical Ltd. His experience in these organizations has allowed him to refine his expertise in the development of medical technologies and products.

Collaborations

Mike has collaborated with talented individuals such as Cara L Ferreira and Eric William Price. These partnerships have contributed to the advancement of his projects and the successful implementation of his innovations.

Conclusion

In summary, Mike Adam is a notable inventor whose work on bifunctional chelating agents has the potential to impact the medical field significantly. His collaborations and career experiences further enhance his contributions to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…